NOVARTIS AG (NVSEF)
Clinical trial NCT06470048 updates: 1. completion date: 2030-07-15 → 2034-07-31 2. primary completion date: 2027-07-06 → 2027-07-30
Clinical trial NCT06470048 updates: 1. completion date: 2030-07-15 → 2034-07-31 2. primary completion date: 2027-07-06 → 2027-07-30
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical